DIFFERENTIAL ASSOCIATIONS BETWEEN PHYSICAL ACTIVITY AND GLYCEMIC CONTROL ACROSS BODY MASS INDEX IN TYPE 2 DIABETES: A COMPARATIVE ANALYSIS OF HBA1C AND FRUCTOSAMINE.
Аннотация
BACKGROUND: Glycated hemoglobin (HbA1c) is the primary biomarker for assessing long-term glycemic control in type 2 diabetes (T2D). However, its wait time of 2-3 months, affects the timely intervention for the identification of acute metabolic enhancements resulting from lifestyle modifications. On the other hand, fructosamine reflects the glycemic regulation for over a period of 2-3 weeks and may provide supplementary short-term monitoring functions. Nevertheless, there is scant information comparing these markers across varying levels of physical activity and body mass index (BMI) strata in people with type 2 diabetes (T2D). OBJECTIVE: To assess HbA1c and fructosamine as indicators of glycemic control in physically active and sedentary people with Type 2 Diabetes, and to investigate if BMI, sex, and glucose-lowering drugs influence the association between physical activity and these glycemic markers. METHODS: This cross-sectional study was conducted at Thumbay Labs in the United Arab Emirates from January to October 2025, included 185 persons with Type 2 Diabetes (T2D), classified as physically active (n=98, engaging in ≥150 minutes of activity per week for over 3 months) or sedentary (n=87). HbA1c and fructosamine were assessed utilizing standardized laboratory techniques. Multivariable linear regression models evaluated the relationships between physical activity and glycemic indicators, controlling for age, sex, BMI, and primary glucose-lowering drug classes, while explicitly testing for interactions between Activity and BMI, as well as Activity and Sex. RESULTS: Physically active participants exhibited lower HbA1c (6.84% vs. 8.07%, p<0.0001) and fructosamine levels (301.0 vs. 362.0 µmol/L, p=0.0001) compared to sedentary individuals. A significant Activity × BMI interaction for HbA1c (β=0.156, p=0.0002) was found, indicating decreased glycemic benefits of physical activity with higher BMI, persisting after controlling for diabetes medications. A similar but weaker effect for fructosamine (β=7.481, p=0.0019) was noted. No notable differences were observed between sexes regarding these markers when BMI was considered. CONCLUSIONS: Physical activity is associated with glycemic control, which is supported by HbA1c and fructosamine levels, even though obesity declines this effect, especially in long-term glycemic memory (HbA1c). Individuals who fall under the T2D and increased BMI category need stronger lifestyle interventions for similar glycemic benefits as those with lower BMI. HbA1c is a more reliable marker for activity-related metabolic benefits in stable T2D, while fructosamine is a useful short-term indicator but not interchangeable.
Ҳали таржима қилинмаган